Teresa Lambe

34.0k total citations · 1 hit paper
95 papers, 4.6k citations indexed

About

Teresa Lambe is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Teresa Lambe has authored 95 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 38 papers in Epidemiology and 35 papers in Immunology. Recurrent topics in Teresa Lambe's work include SARS-CoV-2 and COVID-19 Research (29 papers), Influenza Virus Research Studies (24 papers) and Immune Cell Function and Interaction (22 papers). Teresa Lambe is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (29 papers), Influenza Virus Research Studies (24 papers) and Immune Cell Function and Interaction (22 papers). Teresa Lambe collaborates with scholars based in United Kingdom, United States and Australia. Teresa Lambe's co-authors include Sarah C. Gilbert, Richard J. Cornall, Adrian V. S. Hill, Christopher C. Goodnow, Katie Ewer, Alexandra J. Spencer, John I. Bell, Tanya L. Crockford, Tamara Berthoud and Carola G. Vinuesa and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Teresa Lambe

89 papers receiving 4.6k citations

Hit Papers

A RING-type ubiquitin ligase family member required to re... 2005 2026 2012 2019 2005 200 400 600

Peers

Teresa Lambe
Alejandro B. Balazs United States
Ingo Drexler Germany
Anthony T. Tan Singapore
Julia L. Hurwitz United States
Ali H. Ellebedy United States
Andrea Gambotto United States
Alejandro B. Balazs United States
Teresa Lambe
Citations per year, relative to Teresa Lambe Teresa Lambe (= 1×) peers Alejandro B. Balazs

Countries citing papers authored by Teresa Lambe

Since Specialization
Citations

This map shows the geographic impact of Teresa Lambe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Lambe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Lambe more than expected).

Fields of papers citing papers by Teresa Lambe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Lambe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Lambe. The network helps show where Teresa Lambe may publish in the future.

Co-authorship network of co-authors of Teresa Lambe

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Lambe. A scholar is included among the top collaborators of Teresa Lambe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Lambe. Teresa Lambe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murray, Sam M., Ali Amini, Helen Ferry, et al.. (2025). Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines. Science Immunology. 10(110). eadu4610–eadu4610.
2.
Ferreira, Rui Seabra, Laura de Oliveira Nascimento, M Ferrari, et al.. (2025). Translational science at the undergraduate level: awakening talents to overcome the valley of death - case report. ˜The œJournal of venomous animals and toxins including tropical diseases. 31. e20250005–e20250005.
3.
Bissett, Cameron, Alexandra J. Spencer, Freda Lam, et al.. (2025). Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanisms. The Journal of Experimental Medicine. 223(1).
4.
O’Donnell, Kyle L., et al.. (2024). Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model. International Journal of Molecular Sciences. 25(15). 8516–8516. 2 indexed citations
5.
Leroux‐Roels, Geert, Bruno Salaun, Michel Janssens, et al.. (2023). Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols. Journal of Immunological Methods. 523. 113584–113584. 4 indexed citations
6.
Mitsi, Elena, Mariana O. Diniz, Jesús Reiné, et al.. (2023). Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination. Nature Communications. 14(1). 6815–6815. 30 indexed citations
7.
Ni, Tao, Luiza Mendonça, Yanan Zhu, et al.. (2023). ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface. iScience. 26(10). 107882–107882. 13 indexed citations
8.
Gilbride, Ciarán, Stuart Dowall, Susan Morris, et al.. (2023). Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model. EBioMedicine. 90. 104523–104523. 20 indexed citations
9.
Leroux‐Roels, Geert, Teresa Lambe, Duncan Bellamy, et al.. (2022). Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. Frontiers in Immunology. 13. 984642–984642. 13 indexed citations
10.
Nyagwange, James, Kennedy Mwai, Henry Karanja, et al.. (2022). Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro. International Journal of Infectious Diseases. 127. 11–16. 4 indexed citations
11.
Doremalen, Neeltje van, Jonathan E. Schulz, Danielle R. Adney, et al.. (2022). ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants. Nature Communications. 13(1). 4610–4610. 17 indexed citations
12.
Doremalen, Neeltje van, Victoria A. Avanzato, Friederike Feldmann, et al.. (2022). ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys. npj Vaccines. 7(1). 171–171. 16 indexed citations
13.
Fischer, Robert J., Neeltje van Doremalen, Danielle R. Adney, et al.. (2021). ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. Nature Communications. 12(1). 5868–5868. 29 indexed citations
14.
Spencer, Alexandra J., Paul F. McKay, Sandra Belij‐Rammerstorfer, et al.. (2021). Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice. Nature Communications. 12(1). 2893–2893. 87 indexed citations
15.
Swanson, Phillip A., Marcelino Padilla, Kelly McGlinchey, et al.. (2021). AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T H 1 response with a diverse TCR repertoire. Science Translational Medicine. 13(620). eabj7211–eabj7211. 59 indexed citations
16.
Sharpe, Hannah, Ciarán Gilbride, Elizabeth Allen, et al.. (2020). The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world. Immunology. 160(3). 223–232. 79 indexed citations
17.
18.
Ewer, Katie, Sarah Sebastian, Alexandra J. Spencer, et al.. (2017). Chimpanzee adenoviral vectors as vaccines for outbreak pathogens. Human Vaccines & Immunotherapeutics. 13(12). 3020–3032. 64 indexed citations
19.
Lambe, Teresa, Georgina Bowyer, & Katie Ewer. (2017). A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?. Philosophical Transactions of the Royal Society B Biological Sciences. 372(1721). 20160295–20160295. 22 indexed citations
20.
Chinnakannan, Senthil, Caitlin E. Mullarkey, Marta Ulaszewska, et al.. (2017). Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge. The Journal of Immunology. 199(4). 1333–1341. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026